New US bio-terror law could spell good news for Bavarian Nordic
The Danish biotech company Bavarian Nordic sees it as good news that the US Congress has passed a law to maintain the US bio-terror alert system.
by Kresten Morten Munksgaard
When the US Senate agreed to put aside 2.8 billion dollars to maintain the US bio-terror defence system recently, it did not just spell good news for American citizens, but also for Bavarian Nordic, the Danish company says in a press release.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler:
The canadian market potential is 10 million doses
For abonnenter
Bavarian wins order and raises expectations
For abonnenter
.jpg&w=384&q=75)
